fda warning letters compounded semaglutide telehealth 2024 2025 Beyond the Headlines: to GLP-1 Compounders FDA Warns 30 Telehealth Companies

Perhaps Novo Nordisks most novel offering is a once-monthly ultrasound treatment for obesity, currently in early stages of exploration as part of a collaboration with GE Healthcare

If you purchased a GLP-1 medication through a telehealth platform, keep in mind that you may not always know where it was compounded or under what conditions

Long-Term Results With GLP-1 Average Weight Loss Outcomes Clinical studies show patients may lose between 10% to 20% of their body weight over time when GLP-1 is combined with medical supervision

Free from gluten, dairy, peanut, fish, shellfish, soy, sesame, and egg

International journal of peptides

Moderate alcohol consumption is generally fine with both medications